Clinical Trials Browser

INDUSTRY × Recurrence × denileukin diftitox × Clear all

NCT01432483 2015-01-26

Access Program With Denileukin Diftitox for the Treatment of Patients Currently Receiving Treatment With Commercially Available (Ontak)

No longer available

Neoplasms, Recurrence